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Theoretical determination of two-photon
absorption in biologically relevant pterin
derivatives
Thomas Malcomson *a and Martin J. Paterson b
Given the prevalence of fluorescence spectroscopy in biological systems, and the prevalence of pterin
derivatives throughout biological systems, presented here is an assessment of the two-photon absorption
spectroscopy as it applies to a range of the most commonly studied pterin derivatives. QR-CAMB3LYP//
ccpVTZ calculations suggest that the use of two-photon spectroscopic methods would enable a more
capable differentiation between closely related derivatives in comparison to the one-photon spectra,
which show minimal qualitative deviation. Study of short tail derivatives shows that, in most cases, two-
photon accessible states solely involve the π* LUMO as the particle orbital, with biopterin, neopterin, and
6-(hydroxymethyl)pterin presenting exceptional potential for targetting. Investigation of derivatives in
which the tail contains an aromatic ring resulted in the observation of a series of two-photon accessible
states involving charge transfer from the tail to the pterin moiety, the cross sections of which are highly
dependent on the adoption of a planar geometry. The observation of these states presents a novel
method for tracking the substitution of biologically important molecules such as folic acid and
5-methenyltetrahydrofolylpolyglutamate.
1. Introduction
The pterin family of molecules are defined as low weight het-
erocycles derived from the substitution of a pteridine ring with
a amino (–NH2) and carbonyl (–CvO) groups at the C2 and C4
ring positions, respectively. Although both nitrogen and
oxygen centres are possible targets for nucleophilic attack, the
central pterin moiety (Fig. 1) is more commonly functionalised
through the addition of substituent groups to the C6 position,
located on the pyrazine ring.1
Behaving as weak acids in aqueous solution, pterins form a
dominant equilibrium at pH > 5 consisting of the acidic
(amino) and basic (phenolate) form (Fig. 1)2 with the pKa of
this equilibrium, centred around the protonation state of the
N3 proton, is ca. 8 3 for the derivatives shown in Table 1. The
pKa of other pterin-based protons, specifically those located on
the N1 amino group, are <2.2
Throughout this work, for the ease of discussion, the acidic
and basic forms of each molecule, when appropriate, will be
marked by a subscript letter (PTa and PTb representing the
acidic and basic forms of the unsubstituted pterin moiety,
respectively).
Pterins, and their derivatives, are found throughout
biology. While their oxidised states have been found extensive
medical use, acting as markers for a range of conditions,
including: vitiligo,4 cardiovascular diseases,5,6 along
with activation of immune responses and synthesis of
neurotransmitters,7,8 pterins are also found naturally within
human biology; folic acid (vit B9) acts as a coenzyme during
reactions involved in the synthesis of both purine and pyridine
DNA bases.9 Biopterin (BPT) has been found taking the role of
a coenzyme in hydroxylation reactions in the metabolism of
both amino acids and nitric oxide10,11 while neopterin (NPT),
a BPT metabolite, is synthesised predominantly in activated
macrophages with high levels of NPT found in response to
Fig. 1 Structure of pterin moiety in its acidic (left) and basic (right)
states.
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infections caused by viruses, parasites and intracellular
bacteria.12–17 Despite the role of 5,10-methenyltetrahydrofolyl-
polyglutamate, a derivative of folic acid (FA), in DNA repair as
a light-harvesting antenna in DNA photolyases,18–20 oxidised
pterins have also been shown to cause photo-activated DNA
damage when exposed to UV light.21–25
The ability of pterins to produce singlet oxygen (O2(
1Δg),
denoted as 1O2 for simplicity)
26,27 has garnered particular
interest due to its role in photodynamic therapy (PDT).28,29
This metastable state of molecular oxygen, produced primarily
through photosensitisation, is significantly more reactive than
the triplet ground state (O2(
3∑−g)). The pterin-induced pro-
duction of 1O2 is brought about due to ready access of the
pterin molecules to a triplet excited state through intersystem
crossing,30,31 enabling a spin crossover with the 3O2 state of
molecular oxygen in place of the commonly observed pterin
phosphorescence.26,32
However, the ideal wavelength of light needed to achieve
the production of singlet oxygen is in the region of 350 nm
which has a very poor tissue penetration value as, due to scat-
tering from the cell nuclei, mitochondria, the Golgi apparatus
and the cellular surface itself,33,34 the optical penetration of
biological tissue is low, usually measured in millimetres.35
Tissue penetration varies greatly depending on the tissue type
and the wavelength used, with longer wavelengths appearing
to penetrate to a greater degree, with Stolik et al. reporting a
depth of 4.23 ± 0.03 mm.35
While 1O2 has been shown to be a dominant mediator of
phototoxic effects, it is a short lived species (<200 ns
in vitro).36–38 As a result of this, the diffusion of 1O2 is limited
to short distances (≈1 μm),39–41 limiting the cytotoxicity to
immediate area around the production location. The low
diffusion of 1O2 through a biological medium does, however,
limit its use as a photoactivated target due to the tissue depth
penetration of the UV light required to excite the pterin
molecules.42,43 This limitation can be reduced through with
the use of near IR light (λ = 600–100 nm) via two-photon
absorption (TPA) which, in addition to the increased tissue
penetration of higher wavelength light, increases the spatial
resolution of photo-activation.
Despite this promising avenue of investigation, coupled
with the pterin molecule acting as a design precursor for a
number of fluorescent DNA analogues44,45 and the otherwise
extensive detail to which the photochemistry of these mole-
cules has been investigated,26,27,30–32,46 studies of the potential
two-photon activation of pterin derivatives is poorly explored.
In response to this, we present here a study of the suscepti-
bility of a series of well studied, biochemically relevant pterin
derivatives to two-photon activation through the use of quadra-
tic response (QR) density functional theory (DFT) method-
ologies. The use of these methodologies for the accurate deter-
mination of TPA spectra has been well established across a
range of molecules of both biological and photochemical
importance.47–53
The structures studied here are presented in three
groups: the first involves small functional group alterations
to the core pterin moiety at the C6 (Table 1); the second
involves the inclusion of extended side chains (Fig. 2)
centred around the folic acid structure (FA); the final group-
ing of structures (Fig. 3), centred around 5-methenyltetrahy-
drofolylpolyglutamate (MTHFG), denote a series of biologi-
cal, pterin derived, cofactors. These groups are selected to
Fig. 2 Extended R-groups for pterin derivatives.
Fig. 3 One-photon absorption spectra of pterin derivatives in their
acidic state.
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provide a thorough representation of the TPA viability of
the pterin family of molecules throughout their biological
function.
The successful determination of the TPA spectra for these
derivatives opens up a number of avenues for further investi-
gation, from TPA access to the triplet states of these derivatives
and their potential for 1O2 production, to the ability to track
the presence of specific derivatives despite the one-photon
absorption (OPA) spectra of these structures showing little
qualitative variation.
2. Theoretical methods
Geometry optimisations and TD-DFT calculations were carried
out with the Gaussian16 software package.54,55 Optimisations
utilised the B3LYP functional56–60 with Grimme’s D3 dis-
persion61 and Becke–Johnson dampening62–65 along with the
6-311G** basis set66 with the determination of structural
minima conducted through frequency analysis and noted by
the presence of only positive curvature; the use of this model
chemistry has been well established for giving appropriate geo-
metry determinations for molecules of this type.17,67–71
TD-DFT data was determined using a series of DFT func-
tionals, namely: CAM-B3LYP,72 B3LYP,56–60 BP8673,74 and
PBE0,75 each with the Dunning cc-pVTZ basis.76 CAM-B3LYP
values are reported here due to their agreement with the
UV-Vis spectra of folic acid,77 as well as its robust performance
on similar organic molecules.78,79 The use of CAM-B3LYP for
the QR-DFT calculations has been well established in provid-
ing high accuracy values for similar systems.47–49,80–83
Two-photon cross sections (σTP), as defined through
QR-DFT implemented in Dalton,84 are determined by:
σTP ¼ 8π
3α2ℏ
e4
E2δTP ð1Þ
where:
E ¼ ω
Γ
ð2Þ
such that ω is the photon energy in eV and Γ is a broadening
factor of 0.1 eV, α is the fine line constant, and the transition
strength (δTP) is given by:80
δTP ¼ FδF þ GδG þ HδH ð3Þ
in which F, G, and H vary depending on the polarisation of
light use; under parallel linearly polarised light, F = G = H = 2.
In addition, each component (δF/δG/δH) takes the form:
δF ¼ 1
30
X
α;β
SααSββ ð4Þ
δG ¼ 1
30
X
α;β
SαβSαβ ð5Þ
δH ¼ 1
30
X
α;β
SαβSβα ð6Þ
where α and β are the components of the dipole operator such
that α, β = x, y, z, and the sums contained within each term
run over combinations of these components for the operators
acting between the ground (|0〉), intermediate (|i〉), and final (|
f〉) states, such that:
Sα;β ¼
X
i
h0jμαjiihijμβf i
ωi  ωf2
þ h0jμ
βjijihijμαjf i
ωi  ωf2
ð7Þ
where ωi is the transition frequency to the intermediate
(virtual) state, and ωf is the transition frequency for the final
state; i.e. the state in question.
3. Results and discussion
3.1. Acid vs. base susceptibility for one- and two-photon
absorption
Across pterins involving the addition of small, non-aromatic
substituents, a single dominant (defined here as a state with a
Table 1 Excited state energies (eV) and two-photon cross sections
(GM) of the unsubstituted pterin structure
State
Acid Base
Energy σTP Energy σTP
1 3.8466 0.000 3.6378 0.000
2 4.3353 0.058 3.7888 0.077
3 4.7731 0.001 4.2833 0.000
4 4.9175 0.000 4.6724 0.026
5 5.0735 0.164 4.7912 0.002
6 5.4911 0.006 4.9873 0.003
7 6.0768 0.006 5.3212 0.286
8 6.2832 0.008 5.6911 0.007
9 6.3615 0.260 5.8665 0.010
10 6.5497 0.332 5.9080 0.002
Table 2 R-group variation of investigated pterins
Abbrv. Name R1 R2
PT Pterin –H H
BPT Biopterin –(CHOH)2CH3 H
CPT 6-Carboxypterin –COOH H
DPT 6,7-Dimethylpterin –CH3 –CH3
FPT 6-Formylpterin –CHO H
HPT 6-(Hydroxymethyl)pterin –CH2OH H
MPT 6-Methylpterin –CH3 H
NPT Neopterin –(CHOH)2CH2OH H
RPT Rhamnopterin –(CHOH)3CH3 H
PA Pteroic acid a H
FA Folic acid a H
MFA 10-Methylfolic acid a H
FN Folinic acid b H
MTHF L-5-Methyltetrahydrofolate b H
MTHFG 5,10-Methenyltetrahydrofolyl-
polyglutamate
b H
a R1 groups for pterin derivatives with extended side chains are shown
in Fig. 2. b Structures for derivatives involving biological alterations to
the central pterin moiety are shown in Fig. 3.
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cross section >1.0 GM) can be observed in the acid form; this
state can be seen moving to a lower energy in the basic form, a
trend contrary to that observed in the the OPA spectra (Fig. 4
and 5). When considering the OPA spectra of the base forms
of small-tail derivatives the dominant transitions are to S2 and
S7 for the peaks at approx. 340 nm and 240 nm, respectively.
In the two-photon spectra, these states remain accessible, with
cross-sections for S2 (S1 for NPTb) ranging from 0.1–1.3 GM
while S7 is seen to possess more substantial cross-section
values, ranging from 4.1–10.7 GM. In contrast to the base
spectra, the spectra for the acidic form (Table 4) is less predict-
able. While S2 is still accessible for most derivatives (with the
exception of FPTa & HPTa), the state corresponding to the
higher energy peak is more variable, with dominant tran-
sitions to states S5, S8, S9, or S10 observed, depending on the
derivative. However, similar to what is observed in the base
form, states showing strong oscillator strengths in the OPA
spectra remain accessible in the TPA spectra with ranges for S2
from 0.19–1.1 GM and, with the exception of FPTa, a range of
4.6–9.5 GM for states found in the region of the higher energy
OPA peak. This maintained susceptibility when moving from
one- to two-photon absorption allows for the continued photo-
reactivity of each pterin derivative to be monitored in a similar
manner to those of modern fluorescent spectroscopy methods,
while also utilising of the benefits of TPA spectroscopy, includ-
ing: greater spectroscopic resolution and tissue depth pene-
tration, as well as reduced potential for unnecessary tissue
damage when targetting the higher energy peak, which would
otherwise necessitate the use of a high energy UV light source.
The inclusion of substituents containing an aromatic group,
such as those highlighted in Fig. 2, results in similar trends to
those of the smaller, non-aromatic, substituents in that large
cross-section values relating to the higher energy peak of the
OPA spectra (Fig. 8 and 9) remaining accessible in both acid
and base forms, while the high values observed in lower states
are quenching when adopting the basic form (Tables 5 and 6).
Overall, despite the structures with tails inclusive of aro-
matic groups showing greater similarity between the acid and
base forms than their small tail counterparts, the TPA spectra
mimics the properties of the OPA spectra closely with similar
shifts in state energies. The TPA differs from the OPA spectra,
however, in the emergence of additional accessible states upon
adoption of the base form of a number of derivatives; this,
adding additional possibilities for the identification of the
form present in vitro through the use of fluorescent
spectroscopy.
3.2. Effects of non-aromatic substituents
Tables 3 shows that, regardless of whether in their acidic or
basic form, the unsubstituted pterin molecule (PT) exhibits no
significant two-photon cross section (σTP) with the highest
value of 0.332 GM for S10 of PTa, lying at 6.55 eV. Despite this
low potential, the addition of a substituent at the C6 position
results in a 10-fold increase in the cross sections for the
majority of substituents shown across Tables 2 and 4; the only
structure that does not present an accessible state with a cross
section of greater than 1 GM is FPTa. In contrast to the OPA
spectra (Fig. 4 and 5), which show a significant amount of
overlap in terms of bright regions, the TPA spectra shows
enhanced resolution with accessible states separating; this
would suggest that the use of TPA spectroscopy could allow for
the identification of a specific derivative even when other
derivatives are present. An example of this can be seen in the
NPTa derivative which, despite showing a near equivalent OPA
spectra to most other derivatives (Fig. 4), shows a TPA accessi-
ble state at 5.42 eV for which the only other accessible states in
the region is the 5.32 eV S6 state of RPTa and the 5.30 eV S7
state of DPTb, both of which present a cross section of less
than half the size (4.78 GM (Table 2) and 4.18 GM (Table 4),
respectively). A similar pattern can be observed with the S7
state of BPTb at 5.05 eV and S8 state of HPTb at 5.61 eV which
presents the highest cross-section of all small-tail derivatives
at 39.60 GM.
With the exception of FPT, which consists of a predomi-
nantly HOMO → LUMO+1 transition, the dominant state for
each derivative (Tables 2 and 4) involve the same π–π* tran-
Fig. 5 One-photon absorption spectra of pterin derivatives in their
base form.
Fig. 4 One-photon absorption spectra of pterin derivatives in their
acidic state.
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sition (Fig. 6); the presence of this state represents a transition
that, while energetically effected by the tail, remains
accessible.
3.3. Effect of aromatic substituents
Derivatives including an aromatic moiety in the tail (Fig. 2)
show similar spectral features to that of the small tail deriva-
tives; showing a small number of accessible states with high
cross sectional values spread throughout a manifold of states
that show low to moderate accessibility. The differences
between these derivatives and those containing small tails
becomes evident when assessing the OPA spectra (Fig. 8 and
9), in which the stereotypical shoulder shown at the
300–350 nm range remains present and at a similar intensity
to that of the small tail derivatives while the larger peak seen
at ≈250 nm presents a significant increase in intensity.
In contrast, the TPA spectra appears to consist of states
which can be characterised in one of three ways: charge trans-
fer states, in which density moves from the aromatic ring of
the tail to the pterin moiety; or π–π* states isolated to either
the pterin moiety or the tail; representations of these states are
shown in Fig. 7.
For the acid form (Table 5) shows that, for both PAa and
FAa, the S1 state situated at 3.87 and 3.84 eV, respectively, is
significantly more accessible than its OPA counterpart with
respect to the rest of their corresponding spectra; this state is,
notably, quenched upon adopting the base form (Table 6).
Unlike the S1 state, the second TPA accessible region, rep-
resented by S5 of each derivative in the acid form remains rela-
tively intact in the base form with an average shift from 4.80
eV to 4.40 eV (noting that the TPA accessible S5 state of the
acid form (Table 5) migrates to the S4 position when in the
base form (Table 6)).
The S1 state of these derivatives, which show a large cross
sectional value for both PAa and FAa (Table 5), is characterised
by a charge transfer from the π HOMO, isolated on the pterin
moiety, to the π* LUMO on the aromatic ring of the tail, as
shown in Fig. 7. The methylation of the bridging nitrogen in
MFA (Fig. 2), which causes the structure to fold so that the
phenyl ring of the tail is orientated perpendicular to the plane
Fig. 6 Dominant orbital transition describing the two-photon accessi-
ble state showing high cross sections across small tail pterin derivatives,
as shown for the DPTa structure.
Table 4 State energies (eV) and two-photon cross sections (GM) of pterin derivatives in their base form
State
BPT CPT DPT FPT HPT MPT NPT RPT
E σTP E σTP E σTP E σTP E σTP E σTP E σTP E σTP
1 3.57 0.424 3.45 0.001 3.75 0.116 3.30 0.001 3.64 0.003 3.60 0.022 3.65 1.070 3.64 0.134
2 3.61 0.859 3.73 0.268 3.79 1.330 3.61 0.327 3.73 0.107 3.69 1.340 3.68 0.157 3.66 1.280
3 4.26 0.026 4.10 0.000 4.37 0.009 3.83 0.001 4.30 0.001 4.26 0.011 4.36 0.013 4.31 0.007
4 4.56 0.701 4.28 0.326 4.64 0.882 4.06 0.001 4.59 0.232 4.65 0.703 4.60 0.772 4.62 0.758
5 4.76 0.071 4.31 0.029 4.85 0.026 4.28 0.110 4.78 0.003 4.83 0.532 4.82 0.062 4.81 0.055
6 4.90 0.021 4.81 0.123 5.07 0.040 4.29 2.730 4.96 0.042 4.97 0.032 4.95 0.014 4.96 0.058
7 5.11 4.590 5.05 10.700 5.30 4.180 4.77 0.139 5.22 9.770 5.24 4.440 5.17 4.030 5.18 5.440
8 5.71 0.566 5.28 0.016 5.63 0.848 4.91 0.001 5.61 39.600 5.67 0.078 5.78 0.200 5.74 0.110
9 5.85 0.178 5.39 0.048 5.69 0.064 5.30 0.040 5.66 0.068 5.90 0.209 5.89 0.214 5.75 20.200
10 5.92 0.100 5.44 0.055 5.87 0.151 5.43 0.102 5.85 0.048 5.94 0.035 5.91 1.800 5.93 0.104
Table 3 State energies (eV) and two-photon cross sections (GM) of pterin derivatives in their acidic form
State
BPT CPT DPT FPT HPT MPT NPT RPT
E σTP E σTP E σTP E σTP E σTP E σTP E σTP E σTP
1 3.89 0.007 3.80 0.000 3.99 0.002 3.46 0.000 3.85 0.000 3.87 0.001 4.00 0.014 3.82 0.009
2 4.29 0.646 4.28 0.186 4.32 0.616 3.80 0.000 4.24 0.057 4.25 0.489 4.24 0.497 4.19 0.723
3 4.75 0.031 4.39 0.002 4.85 0.037 4.16 0.343 4.83 0.002 4.83 0.024 4.92 0.120 4.83 0.115
4 4.95 0.099 4.72 0.613 5.00 1.070 4.38 0.002 4.96 0.002 4.95 0.024 5.00 1.150 4.96 0.190
5 4.98 3.010 4.85 0.134 5.01 1.220 4.67 0.660 5.05 0.128 5.03 2.030 5.03 0.037 5.02 0.869
6 5.47 0.181 4.94 0.015 5.52 0.049 4.76 0.002 5.46 0.071 5.48 0.680 5.42 10.900 5.32 4.780
7 6.06 0.307 5.41 0.050 6.13 0.060 5.22 0.027 6.11 0.099 6.14 0.060 5.50 0.663 5.50 0.122
8 6.22 6.630 5.77 0.076 6.28 9.460 5.58 0.036 6.24 8.920 6.30 0.321 6.10 0.101 6.11 0.830
9 6.32 4.640 6.09 0.091 6.38 0.598 5.74 0.114 6.29 0.273 6.34 4.700 6.31 4.650 6.21 3.000
10 6.42 0.282 6.21 9.490 6.43 5.140 6.07 0.659 6.44 0.723 6.46 5.990 6.35 2.740 6.25 3.370
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of the pterin moiety, may explain the near zero cross section
observed for this derivative through the breaking of any π
overlap that would aid in the transfer of electron density. The
reduction in cross section as these derivatives move to their
base form can be explained in a similar manner, in which the
change in electronic structure of the pterin moiety, including
the development of a formal negative charge on the oxygen,
would reduce the ability of this moiety to accommodate charge
from the tail. In contrast, the higher energy state (S5 in the
acid form; S4 in the base form) is characterised by a π–π* tran-
sition isolated to the aromatic ring located in the tail which
explains the observation that, while the cross sections of the
states to change from the acid to base form, the state remains
accessible across both forms.
3.4. Oxidised derivatives
The derivatives achieved through oxidation of the pterin
moiety, shown in Fig. 3, present a significantly blue shifted
spectra compared to structures in which the pterin moiety is
left intact, with the additional feature of increased intensity in
the shoulder region. The TPA spectra of these structures
(Table 7) show a shared accessible state slightly red shifted in
comparison to the lower energy peak of the OPA spectra. A
second, TPA accessible, state can be seen for MTHFG at 5.76
eV with a cross sectional value of 22.40 GM; access to the
MTHFG 4.74 eV S1 state can be achieved with a cross sectional
value of 12.80 GM.
In a similar manner to the pterins involving tails which
contain an aromatic moiety, the oxidised derivatives studied
here present a bright π–π* state that is shared across the
derivatives (Table 7). This state can be found at S4 for FNA (E =
4.95 eV; σTP = 19.5 GM) and S3 for MTHF and MTHFG (E = 4.82
eV; σTP = 27.2 GM and E = 4.91 eV; σTP = 23.0 GM, respectively).
However, while this is the only bright state on the TPA spectra
of FNA and MTHF that overlaps with the lower band of the
OPA spectra, this is not the case with MTHFG. The cyclisation
between the tail and the oxidised pterin moiety results in the
structure of MTHFG adopting a more planar geometry which,
as seen with the acidic form of both PAa and FAa (Table 5),
results in additional bright states. The first of these states is S1
(E = 4.74 eV; σTP = 12.8 GM), which is characterised as a π–π*
transition from a hole orbital with density on the substituted
ring of the oxidised pterin moiety, the 5-membered ring
linking it to the tail, and the aromatic ring of the tail itself, to
Fig. 7 Dominant orbital transitions describing the two-photon accessi-
ble states showing high cross sections in FAa as a representation of
those excitations that are two-photon accessible within derivatives con-
taining an aromatic ring in the tail.
Table 5 State energies (eV) and two-photon cross sections (GM) of
pterin derivatives with extended tails in their acidic form
State
PA FA MFA
E σTP E σTP E σTP
1 3.87 51.100 3.84 60.600 3.58 0.078
2 3.95 0.040 3.95 0.027 4.02 0.086
3 4.22 9.930 4.22 10.200 4.20 0.977
4 4.69 6.830 4.67 0.987 4.54 0.825
5 4.85 41.900 4.82 55.700 4.74 23.100
6 4.89 1.090 4.86 13.900 4.81 5.770
7 4.90 6.360 4.89 0.944 4.89 0.012
8 4.99 0.197 4.99 0.268 4.99 2.800
9 5.09 10.000 5.08 12.900 5.09 1.680
10 5.43 0.000 5.25 3.320 5.23 0.950
Table 6 State energies (eV) and two-photon cross sections (GM) of
pterin derivatives with extended tails in their base form
State
PA FA MFA
E σTP E σTP E σTP
1 3.64 0.765 3.64 0.822 3.56 0.125
2 3.66 0.193 3.66 0.206 3.65 3.020
3 4.32 0.005 4.32 0.006 4.22 0.237
4 4.48 16.700 4.47 34.000 4.31 64.000
5 4.54 6.220 4.54 8.490 4.49 3.500
6 4.69 1.390 4.59 1.880 4.57 3.860
7 4.76 5.890 4.77 3.360 4.61 7.790
8 4.78 0.078 4.78 0.091 4.72 0.131
9 4.92 0.027 4.92 0.036 4.87 1.200
10 5.16 2.560 5.15 3.380 5.10 3.660
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a particle π* orbital isolated on the oxidised pterin moiety. The
second of these states is S8 (E = 5.76 eV; σ
TP = 22.4 GM) which
is characterised by a charge transfer from a π hole orbital iso-
lated on the oxidised pterin moiety to a particle π* orbital on
the aromatic ring of the tail (Fig. 3; bottom); the charge trans-
fer nature of this transition makes the high cross section
associated to it dependent on the planarity of the geometry
compared to the twisted geometry of MTHF in an analogous
manner as seen when comparing the acid forms of FAa and
MFAa (Table 5).
In addition to the TPA accessibility of the low energy
shoulder of the OPA spectra (Fig. 10), all three structures
studied also show significant accessibility for the high
energy OPA peak. Each structure presents a constantly acces-
sible π–π* state isolated to the tail such as that seen in S5 of
FAa (Fig. 7); this state remains at ≈6.80 eV across the struc-
tures. In comparison, the second accessible state of this
band more structurally specific; S22 of FNA (E = 6.52 eV; σ
TP =
12.6 GM) shows a π–π* isolated to the head in which the par-
ticle orbital presents significant Rydberg character, whereas
S23 (E = 6.68 eV; σ
TP = 18.9 GM) in MTHF and S30 (E =
6.90 eV; σTP = 12.0 GM) in MTHFG present charge transfer
from tail to head and π–π* character isolated to the head,
respectively.
Of particular interest in the comparison of the OPA and
TPA spectra is the emergence of TPA accessible states in both
FNA and MTHFG which lie in the dark region between the
OPA spectra (≈6.0 eV; Fig. 10) in the form of a charge transfer
state in which density shifts from the pterin moiety to the aro-
matic ring of the tail; these states are S15 in FNA (E = 6.12 eV;
σTP = 23.2 GM) and S14 in MTHFG (E = 6.18 eV; σ
TP = 16.4 GM).
While these states present similar character to that of S3 in
MTHF (E = 4.82 eV; σTP = 27.2 GM), these states are not accessi-
ble in the OPA spectra.
The accessibility of these two states for MTHFG (S1 & S8) is
a particularly promising find as, in comparison to the OPA
spectra (Fig. 10) which shows minimal differentiation between
MTHFG and MTHF, the TPA spectra does enable the differen-
tiation of these structures. This presents a novel route for
investigating the activity of the methylenetetrahydrofolate
reductase enzyme (MTHFR)85–87 which catalyses the reduction
and decyclisation of MTHFG to MTHF, a cofactor in the con-
version of homocysteine to methionine via the methionine
synthase enzyme, a process vital for DNA reproduction as part
of the cysteine cycle.88,89
Fig. 8 One-photon absorption spectra of the acid form of pterin
derivatives with extended tails.
Table 7 State energies (eV) and two-photon cross sections (GM) of oxi-
dised pterin derivatives
State
FNA MTHF MTHFG
E σTP E σTP E σTP
1 4.73 9.220 4.73 5.680 4.74 12.800
2 4.84 0.575 4.74 6.310 4.76 3.330
3 4.88 3.020 4.82 27.200 4.91 23.000
4 4.95 19.500 5.02 1.240 4.92 0.570
5 5.21 2.900 5.25 4.190 5.09 4.870
6 5.24 1.730 5.26 5.340 5.17 7.310
7 5.27 1.600 5.28 3.100 5.25 1.790
8 5.51 0.374 5.74 0.498 5.76 22.400
9 5.60 4.390 5.86 3.130 5.82 3.310
10 5.88 1.340 5.94 3.750 5.85 0.028
11 5.92 0.175 6.00 6.640 5.97 0.173
12 6.01 1.030 6.02 0.012 6.05 0.159
13 6.01 0.011 6.06 0.113 6.11 0.782
14 6.07 0.079 6.13 1.090 6.18 16.400
15 6.12 23.200 6.16 2.370 6.27 4.120
16 6.16 7.360 6.22 7.850 6.33 1.830
17 6.25 10.100 6.33 2.870 6.36 0.262
18 6.29 1.010 6.36 0.084 6.41 1.180
19 6.34 7.400 6.47 6.050 6.44 2.210
20 6.46 5.200 6.53 4.100 6.52 9.670
21 6.46 2.300 6.57 2.280 6.53 4.410
22 6.52 12.600 6.57 6.940 6.61 1.450
23 6.61 0.817 6.68 18.900 6.63 1.160
24 6.68 2.290 6.71 5.680 6.73 2.400
25 6.73 4.490 6.73 2.980 6.78 27.200
26 6.75 2.490 6.76 41.100 6.80 4.940
27 6.78 13.200 6.81 9.400 6.82 4.260
28 6.84 0.972 6.86 4.900 6.83 2.830
29 6.86 1.300 6.92 1.280 6.86 0.421
30 6.92 0.757 6.95 2.460 6.90 12.000
Fig. 9 One-photon absorption spectra of the base form of pterin
derivatives with extended tails.
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4. Conclusion and outlook
Analysis of the structures presented here reveals a trend in the
accessibility of secondary states (defined here as those that are
of significantly smaller cross sectional value than the domi-
nant TPA peaks for a given structure); this trend shows that,
while these states have a near zero value for a large number of
states when looking to the small tail derivatives (Tables 2
and 4), the cross sectional values of these states increases with
structural complexity. The derivatives containing an aromatic
element in the tail (Tables 5 and 6) show an increased number
of secondary states with a cross sectional value >1 GM while,
when considering the oxidised derivatives (Table 7), the
majority of secondary states present a >1 GM cross section.
Due to the lack of symmetry present throughout the pterin
systems, the parity rules which act to limit the accessible states
of symmetric systems do not apply to the structures studied
here; this has the effect of, theoretically, rendering the entire
singlet manifold assessable, with the cross section of a given
state determined predominantly by the overlap of the particle
and hole orbitals.
Across the pterin structures, TPA accessible states can be
isolated into three different groups of π–π* transitions: those
where both the hole and particle orbitals are located on the
pterin moiety; those where both are orbitals are isolated to the
tail; and those involving charge transfer from the tail to the
pterin moiety. The later two types of transitions are only
present in derivatives containing an aromatic ring in the tail;
derivates without an aromatic ring present TPA accessible
states that are depicted solely by transitions from various hole
orbitals to the same particle orbital (with the exception of FPT,
this particle orbital is shown to be the LUMO). The analysis of
the TPA spectra, when compared to its OPA counterpart, has
shown the potential for targetting specific derivatives despite
the minimal qualitative variation evident in the OPA spectra;
this is particularly relevant for NPTa, BPTb, and HPTb.
Of particular interest are the third category of states, those
involving charge transfer from tail to pterin moiety where the
nature of these states means that access to them is heavily
dependent on the molecular geometry. This geometry depen-
dence enables photochemical investigation of methylation and
substitution events such as the conversion of FA to MFA, or
the ring opening of MTHFG to form MTHF; the utilisation of
TPA in these situations presents the possibility for structural
differentiation that is not observable in the OPA spectra, due
to the density of accessible states, potentially lending new
insight into these biologically important processes.
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